Real-World Austrian Data Show Limits of Chemotherapy in High-Risk DLBCL Patients meeting eligibility criteria for CAR T-cell therapy experienced extremely poor survival with historical standard-of-care regimens.

Real‑world Austrian data show limits of standard chemo for many DLBCL patients and highlight the need for newer therapies. www.hematologyadvisor.com/news/real-world-austrian...

#DLBCL #CancerCare #Oncology #ChemoLimitations #NewTreatments